Evidently, the metastasizing cells’ diverse extracellular environment and their own substrate-sensing proteome may be a major determinant of the biophysical phenotypes that arise throughout prostate cancer progression, which may be more diverse in vivo than those reported here for monolayers plated on fibronectin. The gene discussed is FN1; the disease is Familial prostate cancer.